<?xml version="1.0" encoding="UTF-8"?>
<ref id="BST-49-551C90">
 <label>90</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Tolosa</surname>, 
    <given-names>E.</given-names>
   </string-name>, 
   <string-name>
    <surname>Vila</surname>, 
    <given-names>M.</given-names>
   </string-name>, 
   <string-name>
    <surname>Klein</surname>, 
    <given-names>C.</given-names>
   </string-name> and 
   <string-name>
    <surname>Rascol</surname>, 
    <given-names>O.</given-names>
   </string-name>
  </person-group> (
  <year>2020</year>) 
  <article-title>LRRK2 in Parkinson disease: challenges of clinical trials</article-title>. 
  <source>Nat. Rev. Neurol.</source>
  <volume>16</volume>, 
  <fpage>97</fpage>â€“
  <lpage>107</lpage>
  <pub-id pub-id-type="doi">10.1038/s41582-019-0301-2</pub-id>
  <pub-id pub-id-type="pmid">31980808</pub-id>
 </mixed-citation>
</ref>
